Sanofi Pasteur Refuses U.S. Army’s Request For ‘Fair’ U.S. Pricing Of Experimental Zika Vaccine Developed With Federal Grants

STAT: Sanofi rejects U.S. Army request for ‘fair’ pricing for a Zika vaccine
“Sanofi Pasteur has rejected a request from the U.S. Army to set an affordable U.S. price for a Zika virus vaccine that the company is developing with American taxpayer funds, prompting an angry response from Senator Bernie Sanders. For months, Sanders has pushed the Army to negotiate a more favorable agreement with Sanofi, which is one of the world’s largest vaccine makers and which has already received a $43 million U.S. research grant. But Sanofi recently refused, according to an Army timeline of events reviewed by STAT…” (Silverman, 5/17).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.